{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:31:43Z","timestamp":1772836303949,"version":"3.50.1"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,22]]},"DOI":"10.18632\/oncotarget.4620","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T16:51:29Z","timestamp":1443459089000},"page":"25988-26001","source":"Crossref","is-referenced-by-count":21,"title":["Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression"],"prefix":"10.18632","volume":"6","author":[{"given":"Fat-Moon","family":"Suk","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyr-Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Primary Care Medicine, Taipei Medical University Hospital, Taipei, Taiwan"},{"name":"Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-Jye","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Primary Care Medicine, Taipei Medical University Hospital, Taipei, Taiwan"},{"name":"Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hsin","family":"Hsine","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Ju","family":"Liao","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Uei","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chih","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"},{"name":"Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiographics.14.1.8128042","article-title":"Imaging of childhood non-Hodgkin lymphoma: assessment by histologic subtype","volume":"14","author":"Iyer","year":"1994","journal-title":"Radiographics"},{"key":"2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","article-title":"Epidemiology: clues to the pathogenesis of Burkitt lymphoma","volume":"156","author":"Magrath","year":"2012","journal-title":"Brit J Haematol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Bailey","year":"2012","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3960\/jslrt.51.7","article-title":"BCL2 and MYC dual-hit lymphoma\/leukemia","volume":"51","author":"Tomita","year":"2011","journal-title":"J Clin Exp Hematop"},{"key":"5","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3816\/CLM.2009.s.017","article-title":"Burkitt lymphoma\/leukemia: improving prognosis","volume":"9","author":"Stock","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2040620713514682","article-title":"Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers","volume":"5","author":"Fenske","year":"2014","journal-title":"Ther Adv Hematol"},{"key":"7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","article-title":"Perilous journey: a tour of the ubiquitin-proteasome system","volume":"24","author":"Mayor","year":"2014","journal-title":"Trends Cell Biol"},{"key":"8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/EB0410099","article-title":"The role of the ubiquitin-proteasome system in ER quality control","volume":"41","author":"Ye","year":"2005","journal-title":"Essays Biochem"},{"key":"9","first-page":"a009423","article-title":"Disruption of protein quality control in Parkinson's disease","volume":"2","author":"Petrucelli","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1258\/ebm.2010.010327","article-title":"The role of the ubiquitin proteasome system in Alzheimer's disease","volume":"236","author":"Riederer","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1309\/44HW-5YCJ-FLLP-3R56","article-title":"The proteasome: a new target for novel drug therapies","volume":"116","author":"Ross","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"12","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Blad\u00e9","year":"2005","journal-title":"New Engl J Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1535-7163.MCT-04-0338","article-title":"Proteasome inhibitor therapy in multiple myeloma","volume":"4","author":"Anderson","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"14","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2002-08-2543","article-title":"Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341","volume":"101","author":"Anderson","year":"2003","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.1158\/0008-5472.CAN-05-2394","article-title":"Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells","volume":"65","author":"McConkey","year":"2005","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2091-9-S1-S1","article-title":"Targeting the UPS as therapy in multiple myeloma","volume":"9","author":"Anderson","year":"2008","journal-title":"BMC Biochem"},{"key":"17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/sj.bjc.6601250","article-title":"Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation","volume":"89","author":"Bomsztyk","year":"2003","journal-title":"Brit J Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1073\/pnas.0607595104","article-title":"Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis","volume":"104","author":"Wadhwa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19","first-page":"85","article-title":"The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression","volume":"1765","author":"Murray","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"20","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1128\/MCB.22.13.4535-4543.2002","article-title":"c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs","volume":"22","author":"Hentze","year":"2002","journal-title":"Mol Cell Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cellsig.2008.01.016","article-title":"PKC\u03b4 regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K","volume":"20","author":"Feliers","year":"2008","journal-title":"Cell Signal"},{"key":"22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35060131","article-title":"ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation","volume":"3","author":"Ronai","year":"2001","journal-title":"Nat Cell Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.febslet.2008.04.051","article-title":"Arginine methylation of hnRNP K enhances p53 transcriptional activity","volume":"582","author":"Hu","year":"2008","journal-title":"FEBS Lett"},{"key":"24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2005.09.032","article-title":"hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage","volume":"123","author":"Jackson","year":"2005","journal-title":"Cell"},{"key":"25","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1073\/pnas.0402889101","article-title":"Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis","volume":"101","author":"Chock","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1038\/emboj.2012.293","article-title":"SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage","volume":"31","author":"Chung","year":"2012","journal-title":"EMBO, J"},{"key":"27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1006\/jmbi.1999.2818","article-title":"High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor","volume":"289","author":"Tjandra","year":"1999","journal-title":"J Mol Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2005-09-3732","article-title":"A MAPK\/HNRPK pathway controls BCR\/ABL oncogenic potential by regulatingmRNA translation","volume":"107","author":"Perrotti","year":"2006","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20100158","article-title":"Mechanisms, regulation and consequences of protein SUMOylation","volume":"428","author":"Henley","year":"2010","journal-title":"Biochem J"},{"key":"30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(00)00139-6","article-title":"Ubiquitin-like proteins: new wines in new bottles","volume":"248","author":"Kamitani","year":"2000","journal-title":"Gene"},{"key":"31","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1038\/sj.onc.1208210","article-title":"A role for Ubc9 in tumorigenesis","volume":"24","author":"Beck","year":"2005","journal-title":"Oncogene"},{"key":"32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ncb1415","article-title":"Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis","volume":"8","author":"Baek","year":"2006","journal-title":"Nat Cell Biol"},{"key":"33","first-page":"1293","article-title":"Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma","volume":"7","author":"Otani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cbf.1562","article-title":"Over-expression of SUMO-1 induces the up-regulation of heterogeneous nuclear ribonucleoprotein A2\/B1 isoform B1 (hnRNP A2\/B1 isoform B1) and uracil DNA glycosylase (UDG) in hepG2 cells","volume":"27","author":"Waye","year":"2009","journal-title":"Cell Biochem Funct"},{"key":"35","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/MCB.24.9.3623-3632.2004","article-title":"SUMO modification of heterogeneous nuclear ribonucleoproteins","volume":"24","author":"Matunis","year":"2004","journal-title":"Mol Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1042\/BST0360874","article-title":"SUMO under stress","volume":"36","author":"Bossis","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"37","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/nar\/gkg246","article-title":"Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription","volume":"31","author":"Bonham","year":"2003","journal-title":"Nucleic acids research"},{"key":"38","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/MCB.16.5.2350","article-title":"Heterogeneous nuclear ribonucleoprotein K is a transcription factor","volume":"16","author":"Levens","year":"1996","journal-title":"Mol Cell Biol"},{"key":"39","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/cdd.2010.24","article-title":"The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients","volume":"17","author":"Chang","year":"2010","journal-title":"Cell Death Differ"},{"key":"40","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/onc.2009.55","article-title":"Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells","volume":"28","author":"Chang","year":"2009","journal-title":"Oncogene"},{"key":"41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(01)00212-4","article-title":"Lipoxygenase mRNA silencing in erythroid differentiation: The 3\u2032UTR regulatory complex controls 60S ribosomal subunit joining","volume":"104","author":"Hentze","year":"2001","journal-title":"Cell"},{"key":"42","doi-asserted-by":"crossref","first-page":"10215","DOI":"10.1158\/0008-5472.CAN-08-1066","article-title":"IL-6-induced stimulation of c-Myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1","volume":"68","author":"Lichtenstein","year":"2008","journal-title":"Cancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12185-014-1514-1","article-title":"The impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib\/dexamethasone therapy","volume":"99","author":"Takezako","year":"2014","journal-title":"Int J Hematol"},{"key":"44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"Fonseca","year":"2011","journal-title":"Leukemia"},{"key":"45","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.18632\/oncotarget.3251","article-title":"Anti-\u03b2B-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"46","article-title":"Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma","author":"Parekh","year":"2015","journal-title":"Oncotarget"},{"key":"47","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.3390\/molecules20034516","article-title":"N-Hydroxycinnamide derivatives of osthole ameliorate hyperglycemia through activation of AMPK and p38 MAPK","volume":"20","author":"Liang","year":"2015","journal-title":"Molecules"},{"key":"48","doi-asserted-by":"crossref","first-page":"e0118674","DOI":"10.1371\/journal.pone.0118674","article-title":"Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells","volume":"10","author":"Liang","year":"2015","journal-title":"PLOS ONE"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22308","article-title":"Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells","author":"Liang","year":"2015","journal-title":"Mol Carcinog"},{"key":"50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.04.002","article-title":"N-Hydroxycinnamide derivatives of osthole inhibit cell migration and invasion by suppressing Smad2 and Akt pathways in human colorectal adenocarcinoma cells","volume":"217","author":"Liang","year":"2014","journal-title":"Chem Biol Interact"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T14:13:12Z","timestamp":1589379192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":50,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2015,9,22]]}},"alternative-id":["4620","26317903"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4620","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,17]]}}}